S. M. Rabbur Reza
Chief Operating Officer bei BEXIMCO PHARMACEUTICALS LIMITED
Profil
S.
M.
Rabbur Reza currently works at Nuvista Pharma Ltd., as Managing Director, Beximco Pharma API Ltd., as Managing Director, Beximco Pharmaceuticals Ltd., as Chief Operating Officer from 2005, American Society of Health-System Pharmacists, Inc., as Member, United Nations Environment Programme, as Member, and Pharmaceutical Society of Australia, as Member.
Mr. Reza also formerly worked at Synovia Pharma Plc, as Chief Executive Officer.
Mr. Reza received his Masters Business Admin degree from Queensland University of Technology and undergraduate degree from the University of the Punjab.
Aktive Positionen von S. M. Rabbur Reza
| Unternehmen | Position | Beginn |
|---|---|---|
| BEXIMCO PHARMACEUTICALS LIMITED | Chief Operating Officer | 01.03.2005 |
American Society of Health-System Pharmacists, Inc.
 American Society of Health-System Pharmacists, Inc. Hospital/Nursing ManagementHealth Services American Society of Health-System Pharmacists provides medical and health care services. It represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care and other components of health care systems. The company was founded in 1942 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 02.05.2011 |
| Pharmaceutical Society of Australia | Corporate Officer/Principal | 02.05.2011 |
| United Nations Environment Programme | Corporate Officer/Principal | 05.05.2011 |
Nuvista Pharma Ltd.
 Nuvista Pharma Ltd. Pharmaceuticals: MajorHealth Technology Nuvista Pharma Ltd. manufactures and distributes pharmaceutical products. The company was founded in 1964 and is headquartered in Dhaka, Bangladesh. | Chief Executive Officer | - |
| Beximco Pharma API Ltd. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von S. M. Rabbur Reza
| Unternehmen | Position | Ende |
|---|---|---|
Synovia Pharma Plc
 Synovia Pharma Plc Pharmaceuticals: MajorHealth Technology Part of Beximco Pharmaceuticals Ltd., Synovia Pharma Plc operates as a Bangladeshi biopharmaceutical company. The private company is based in Dhaka, Bangladesh. The company was founded in 1958. The CEO is Muin Uddin Mazumder. Synovia Pharma was acquired by Beximco Pharmaceuticals Ltd. from Sanofi on October 01, 2021 for $0.47 million. | Chief Executive Officer | - |
Ausbildung von S. M. Rabbur Reza
| Queensland University of Technology | Masters Business Admin |
| University of the Punjab | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BEXIMCO PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
American Society of Health-System Pharmacists, Inc.
American Society of Health-System Pharmacists, Inc. Hospital/Nursing ManagementHealth Services American Society of Health-System Pharmacists provides medical and health care services. It represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care and other components of health care systems. The company was founded in 1942 and is headquartered in Bethesda, MD. | Health Services |
| United Nations Environment Programme | Government |
Nuvista Pharma Ltd.
Nuvista Pharma Ltd. Pharmaceuticals: MajorHealth Technology Nuvista Pharma Ltd. manufactures and distributes pharmaceutical products. The company was founded in 1964 and is headquartered in Dhaka, Bangladesh. | Health Technology |
| Pharmaceutical Society of Australia | |
Synovia Pharma Plc
Synovia Pharma Plc Pharmaceuticals: MajorHealth Technology Part of Beximco Pharmaceuticals Ltd., Synovia Pharma Plc operates as a Bangladeshi biopharmaceutical company. The private company is based in Dhaka, Bangladesh. The company was founded in 1958. The CEO is Muin Uddin Mazumder. Synovia Pharma was acquired by Beximco Pharmaceuticals Ltd. from Sanofi on October 01, 2021 for $0.47 million. | Health Technology |
| Beximco Pharma API Ltd. |
